| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: Results from the FAMOUS study
|
P.J., Goebell
|
|
2014
|
32 |
3 |
p. 362-370
9 p.
|
artikel
|
| 2 |
Biomarkers of renal cell carcinoma
|
Ngo, Tin C.
|
|
2014
|
32 |
3 |
p. 243-251
9 p.
|
artikel
|
| 3 |
Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder
|
Xylinas, Evanguelos
|
|
2014
|
32 |
3 |
p. 230-242
13 p.
|
artikel
|
| 4 |
Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus
|
Amato, Robert J.
|
|
2014
|
32 |
3 |
p. 345-354
10 p.
|
artikel
|
| 5 |
Commentary on “A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.” Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Victoria, Australia.
|
Gottschalk, Alexander
|
|
2014
|
32 |
3 |
p. 374-375
2 p.
|
artikel
|
| 6 |
Commentary on “Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.” Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Harvard Radiation Oncology Program, Boston, MA.
|
Gottschalk, Alexander
|
|
2014
|
32 |
3 |
p. 373-374
2 p.
|
artikel
|
| 7 |
Commentary on “Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911).” Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups. Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France.
|
Ritter, Mark A.
|
|
2014
|
32 |
3 |
p. 372-373
2 p.
|
artikel
|
| 8 |
Commentary on “Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus.” Kalakota K, Liauw SL, Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL.
|
Gottschalk, Alexander
|
|
2014
|
32 |
3 |
p. 374-
1 p.
|
artikel
|
| 9 |
Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: A review
|
Masterson, Timothy A.
|
|
2014
|
32 |
3 |
p. 261-271
11 p.
|
artikel
|
| 10 |
Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: Applying RNA-sequencing analysis on archived specimens
|
Sharron Lin, Xuanhui
|
|
2014
|
32 |
3 |
p. 327-336
10 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2014
|
32 |
3 |
p. i-
1 p.
|
artikel
|
| 12 |
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer
|
Ritter, Rene
|
|
2014
|
32 |
3 |
p. 337-344
8 p.
|
artikel
|
| 13 |
George Russell Prout Jr., M.D., 1924–2013, Founding Editor, Urologic Oncology
|
Droller, Michael J.
|
|
2014
|
32 |
3 |
p. 217-218
2 p.
|
artikel
|
| 14 |
Highlights from the first symposium on upper tract urothelial carcinoma
|
Matin, Surena F.
|
|
2014
|
32 |
3 |
p. 309-316
8 p.
|
artikel
|
| 15 |
Impact of CYP1A1, GSTM1, and GSTT1 polymorphisms in overall and specific prostate cancer survival
|
Acevedo, Cristián A.
|
|
2014
|
32 |
3 |
p. 280-290
11 p.
|
artikel
|
| 16 |
Incorporating biomarker research in a real-world setting: Challenges of a prophecy
|
Shariat, Shahrokh F.
|
|
2014
|
32 |
3 |
p. 219-221
3 p.
|
artikel
|
| 17 |
Information for Authors
|
|
|
2014
|
32 |
3 |
p. IBC-
1 p.
|
artikel
|
| 18 |
Masthead
|
|
|
2014
|
32 |
3 |
p. IFC-
1 p.
|
artikel
|
| 19 |
Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer 1 1 Funding: This work was supported by a Department of Defense Prostate Cancer Physician Training Award (W81XWH-08-1-0283) presented to Dr. Hu.
|
Kowalczyk, Keith J.
|
|
2014
|
32 |
3 |
p. 303-308
6 p.
|
artikel
|
| 20 |
Percentage of cancer involvement in positive cores can predict unfavorable disease in men with low-risk prostate cancer but eligible for the prostate cancer international: Active surveillance criteria
|
Russo, Giorgio Ivan
|
|
2014
|
32 |
3 |
p. 291-296
6 p.
|
artikel
|
| 21 |
Prognostic significance of indeterminate lung nodules in renal cell carcinoma 1 1 This study was supported by the John Estrella Foundation for Cancer Research and by the Dana Farber/Harvard Kidney Cancer Center.
|
Xu, Rena
|
|
2014
|
32 |
3 |
p. 355-361
7 p.
|
artikel
|
| 22 |
Prostate cancer biomarkers: An update
|
Romero Otero, Javier
|
|
2014
|
32 |
3 |
p. 252-260
9 p.
|
artikel
|
| 23 |
Survey Section Editorial Board
|
|
|
2014
|
32 |
3 |
p. 371-
1 p.
|
artikel
|
| 24 |
Table of Contents
|
|
|
2014
|
32 |
3 |
p. ii-iv
nvt p.
|
artikel
|
| 25 |
The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro 1 1 Funding to CRW from American Cancer Society Chris DiMarco Institutional Research Grant and to JAC from NIH/NCI CA136665, CA104505, CA104505-05S1 and Mayo Clinic Institutional funding. Short tandem repeat DNA analysis was performed by the Mayo Clinic Cancer Center Genotyping Core. Mayo Clinic Cancer Center is supported in part by an NCI Cancer Center Support Grant 5P30 CA15083-37.
|
Becker, Marie N.
|
|
2014
|
32 |
3 |
p. 317-326
10 p.
|
artikel
|
| 26 |
The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy
|
Mandel, Philipp
|
|
2014
|
32 |
3 |
p. 297-302
6 p.
|
artikel
|
| 27 |
The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research
|
Ristau, Benjamin T.
|
|
2014
|
32 |
3 |
p. 272-279
8 p.
|
artikel
|
| 28 |
Urine markers for detection and surveillance of bladder cancer
|
Xylinas, Evanguelos
|
|
2014
|
32 |
3 |
p. 222-229
8 p.
|
artikel
|
Tijdschrift beschrijving